Publication & Citation Trends
Publications
0 total
120 Real World Safety and Efficacy of Neoadjuvant Chemoimmunotherapy in Resectable NSCLC
Cited by 0
Semantic Scholar
117 Safety and Efficacy of Neoadjuvant Chemoimmunotherapy in Squamous Cell Lung Cancer: A Retrospective UK Multicentre Study
Cited by 0
Semantic Scholar
109 Impact of ipilimumab/nivolumab on mesothelioma treatment and outcomes for the very elderly (80+ years): results from a large tertiary centre
Cited by 0
Semantic Scholar
110 Experience of ipilimumab/nivolumab treatment for malignant mesothelioma (MM): results from a large tertiary centre
Cited by 0
Semantic Scholar
151 Real-world prognostic value of ePROMs in first-line osimertinib for EGFR-mutant NSCLC: a single-centre cohort
Cited by 0
Semantic Scholar
300 TRAcking thoracic Cancer Evolution through therapy (Rx) EVO (TRACERx EVO)
Cited by 0
Semantic Scholar
A global phase 2/3, randomized, open-label trial of BNT327/PM8002 in combination with chemotherapy (chemo) in first-line (1L) non-small cell lung cancer (NSCLC).
Cited by 2
Semantic Scholar
Abstract LB260: Potential prognostic/predictive biomarkers for sacituzumab govitecan in EVOKE-01
Cited by 1
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(91)
Lung Cancer Research Studies
(53)
Cancer Genomics and Diagnostics
(34)
Lung Cancer Diagnosis and Treatment
(31)
Cancer Immunotherapy and Biomarkers
(30)
Affiliations
Christie's
Manchester Academic Health Science Centre
The Francis Crick Institute
Cancer Research UK
University of Manchester